Catalys Pacific Fund, LP 4
4 · Mineralys Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Slingsby Brian Taylor
Director10% Owner
Transactions
- Other
Stock Option
2024-05-22−22,000→ 0 totalExercise: $12.52Exp: 2034-05-22→ Common Stock (22,000 underlying) - Other
Stock Option
2024-05-22+22,000→ 22,000 total(indirect: See footnote)Exercise: $12.52Exp: 2034-05-22→ Common Stock (22,000 underlying)
Footnotes (3)
- [F1]Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP.
- [F2]The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting.
- [F3]Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.